449 related articles for article (PubMed ID: 32728654)
1. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.
Somasundaram NP; Ranathunga I; Ratnasamy V; Wijewickrama PSA; Dissanayake HA; Yogendranathan N; Gamage KKK; de Silva NL; Sumanatilleke M; Katulanda P; Grossman AB
J Endocr Soc; 2020 Aug; 4(8):bvaa082. PubMed ID: 32728654
[TBL] [Abstract][Full Text] [Related]
2. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Glinsky GV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2/COVID-19: a primer for cardiologists.
de Vries AAF
Neth Heart J; 2020 Jul; 28(7-8):366-383. PubMed ID: 32671650
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations.
Miller R; Ashraf AP; Gourgari E; Gupta A; Kamboj MK; Kohn B; Lahoti A; Mak D; Mehta S; Mitchell D; Patel N; Raman V; Reynolds DG; Yu C; Krishnan S
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00262. PubMed ID: 34268455
[TBL] [Abstract][Full Text] [Related]
5. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.
He Y; Wang J; Li F; Shi Y
Front Microbiol; 2020; 11():1302. PubMed ID: 32582134
[TBL] [Abstract][Full Text] [Related]
6. Pediatric endocrinopathies related to COVID-19: an update.
Memar EHE; Mohsenipour R; Sadrosadat ST; Rostami P
World J Pediatr; 2023 Sep; 19(9):823-834. PubMed ID: 36480134
[TBL] [Abstract][Full Text] [Related]
7. Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era.
Rajendran DK; Rajagopal V; Alagumanian S; Santhosh Kumar T; Sathiya Prabhakaran SP; Kasilingam D
Virusdisease; 2020 Jun; 31(2):161-173. PubMed ID: 32656310
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
Park SE
Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
[TBL] [Abstract][Full Text] [Related]
9. [Practical recommendations for screening and management of functional disorders of the adrenal cortex in cases of SARS-CoV-2 infections].
Masjkur J; Barthel A; Kanczkowski W; Müller G; Bornstein SR
Internist (Berl); 2022 Jan; 63(1):4-11. PubMed ID: 34928398
[TBL] [Abstract][Full Text] [Related]
10. Dermatological Manifestations in Patients With SARS-CoV-2: A Systematic Review.
Almutairi A; Alfaleh M; Alasheikh M
Cureus; 2020 Jul; 12(7):e9446. PubMed ID: 32775112
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.
Lisco G; De Tullio A; Stragapede A; Solimando AG; Albanese F; Capobianco M; Giagulli VA; Guastamacchia E; De Pergola G; Vacca A; Racanelli V; Triggiani V
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209964
[TBL] [Abstract][Full Text] [Related]
12. Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care.
Garg MK; Gopalakrishnan M; Yadav P; Misra S
Indian J Endocrinol Metab; 2020; 24(5):381-386. PubMed ID: 33489841
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 spread to endocrine organs is associated with obesity: an autopsy study of COVID-19 cases.
Poma AM; Basolo A; Alì G; Bonuccelli D; Di Stefano I; Conti M; Mazzetti P; Sparavelli R; Vignali P; Macerola E; Pistello M; Santini F; Basolo F; Toniolo A
Endocrine; 2024 Jan; 83(1):110-117. PubMed ID: 37698811
[TBL] [Abstract][Full Text] [Related]
14. Endocrine manifestations of COVID-19 in children: A scoping review.
Nimali Seneviratne S; Kumarihamy Karunathilake CN; Pallegama CM; Malintha Lahiru TG; Jayarajah U
Best Pract Res Clin Endocrinol Metab; 2023 Jul; 37(4):101792. PubMed ID: 37453832
[TBL] [Abstract][Full Text] [Related]
15. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D.
de Las Heras N; Martín Giménez VM; Ferder L; Manucha W; Lahera V
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967329
[TBL] [Abstract][Full Text] [Related]
16. A review on human reproductive systems encountering with the severe acute respiratory syndrome coronavirus 2 infection.
Samadian E; Aghcheli B; Gharaei R; Tabarraei A
Int J Reprod Biomed; 2023 Jan; 21(1):1-16. PubMed ID: 36875501
[TBL] [Abstract][Full Text] [Related]
17. Meningoencephalitis from SARS-CoV-2 infection.
Hafizi F; Kherani S; Shams M
IDCases; 2020; 21():e00919. PubMed ID: 32775207
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.
Puig-Domingo M; Marazuela M; Yildiz BO; Giustina A
Endocrine; 2021 May; 72(2):301-316. PubMed ID: 33963516
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and metabolic complications of COVID-19: lessons learned and future prospects.
Esmaeilzadeh A; Elahi R; Siahmansouri A; Maleki AJ; Moradi A
J Mol Endocrinol; 2022 Oct; 69(3):R125-R150. PubMed ID: 35900847
[TBL] [Abstract][Full Text] [Related]
20. Endocrine Disorders and COVID-19.
Oguz SH; Yildiz BO
Annu Rev Med; 2023 Jan; 74():75-88. PubMed ID: 36151047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
